رجوع
نطاق اليوم
KWD 26.98
KWD 28.30
نطاق 52 أسبوعًا
KWD 7.73
KWD 42.27
حجم التداول
189,345
متوسط 50 يوم / 200 يوم
KWD 28.03
/
KWD 23.20
الإغلاق السابق
KWD 27.91
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.3 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | -28.2 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 43.330
+53.4%
Low: KWD 40.000
High: KWD 47.000
ربحية السهم المستقبلية
-KWD 3.363
الإيرادات المقدّرة
13 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
-KWD 3.583
-KWD 3.583 – -KWD 3.583
|
66 M | 1 |
| FY2029 |
-KWD 4.737
-KWD 4.737 – -KWD 4.737
|
30 M | 1 |
| FY2028 |
-KWD 4.766
-KWD 5.474 – -KWD 3.282
|
0 | 5 |
النقاط الرئيسية
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -88.09M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-28.22%
ROIC-18.91%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.02
Current Ratio26.17
Interest Coverage0.00
التقييم
P/E Ratio
-9.25
P/B Ratio2.13
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -111.48M |
| ROE | -28.22% | ROA | -21.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -88.09M |
| ROIC | -18.91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 26.17 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.25 | P/B Ratio | 2.13 |
| P/S Ratio | N/A | PEG Ratio | -0.02 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.03B | Enterprise Value | 989.90M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -111.48M | -78.31M | -34.79M | -10.65M |
| EPS (Diluted) | -2.86 | -0.38 | -0.19 | -0.05 |
| Gross Profit | -1.02M | -839,000.0 | -112,000.0 | -15,000.0 |
| Operating Income | -125.10M | -83.06M | -36.18M | -10.37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 512.43M | 314.93M | 155.42M | 31.60M |
| Total Liabilities | 27.78M | 9.51M | 181.06M | 12.10M |
| Shareholders' Equity | 484.65M | 305.43M | -25.63M | 19.51M |
| Total Debt | 11.48M | 1.48M | 2.15M | 10.44M |
| Cash & Equivalents | 52.65M | 56.81M | 70.17M | 31.16M |
| Current Assets | 498.56M | 309.80M | 150.87M | 31.27M |
| Current Liabilities | 19.05M | 8.77M | 8.80M | 1.66M |